Literature DB >> 4124605

Evolution of EEG and visual evoked response changes in Jakob-Creutzfeldt disease.

R G Lee, R D Blair.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4124605     DOI: 10.1016/0013-4694(73)90169-7

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


× No keyword cloud information.
  8 in total

1.  Temporal evolution of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.

Authors:  G K Schlenska; G F Walter
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

2.  Unusual EEG findings in a case of Creutzfeldt-Jakob disease.

Authors:  J P Malin; K Weissenborn; J Haas; G F Walter
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

3.  Analysis of clinical and electrophysiological findings in Jakob-Creutzfeldt disease.

Authors:  I Szirmai; A Guseo; J Czopf; G Pálffy
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-12-30

4.  The significance of cyclic EEG changes in Creutzfeldt-Jakob disease: prognostic value of their course in 9 patients.

Authors:  M G Terzano; D Mancia; O Zacchetti; G C Manzoni
Journal:  Ital J Neurol Sci       Date:  1981-08

5.  Electroencephalographic and clinicopathological studies on Creutzfeldt-Jakob syndrome.

Authors:  K Goto; H Umezaki; M Suetsugu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-10       Impact factor: 10.154

6.  Unusual findings in Creutzfeldt-Jakob disease. Case report.

Authors:  M Signorino; A R Giovagnoli; G Sirocchi; B Censori
Journal:  Ital J Neurol Sci       Date:  1988-06

7.  Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease. A pharmacological evoked potential study.

Authors:  U Aguglia; R L Oliveri; A Gambardella; A Quattrone
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

8.  A Creutzfeldt-Jakob like syndrome due to lithium toxicity.

Authors:  S J Smith; R S Kocen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.